Aydin Huseynov
Stock Analyst at Ladenburg Thalmann
(1.02)
# 2,748
Out of 4,413 analysts
54
Total ratings
33.33%
Success rate
-22.86%
Average return
Main Sectors:
Top Industries:
32 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALRN Aileron Therapeutics | Maintains: Buy | $9 → $19 | $4.92 | +286.18% | 2 | Apr 18, 2024 | |
| ACRV Acrivon Therapeutics | Maintains: Buy | $18 → $14 | $10.00 | +40.00% | 1 | Apr 5, 2024 | |
| SPRB Spruce Biosciences | Downgrades: Neutral | n/a | $0.71 | - | 3 | Mar 14, 2024 | |
| BDRX Biodexa Pharmaceuticals | Initiates: Buy | $8 | $1.31 | +510.69% | 1 | Feb 8, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $7 | $1.77 | +295.48% | 1 | Dec 27, 2023 | |
| ZURA Zura Bio | Initiates: Buy | $10 | $4.64 | +115.52% | 1 | Oct 10, 2023 | |
| COEP Coeptis Therapeutics | Initiates: Buy | $3 | $0.33 | +795.79% | 1 | Sep 22, 2023 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $10 → $6 | $1.93 | +210.88% | 2 | Aug 14, 2023 | |
| ATHE Alterity Therapeutics | Maintains: Buy | $20 → $10 | $2.20 | +355.58% | 3 | Jun 5, 2023 | |
| CRVS Corvus Pharmaceuticals | Maintains: Buy | $4 → $10 | $1.58 | +532.91% | 2 | May 30, 2023 | |
| PALI Palisade Bio | Maintains: Buy | $375 → $240 | $6.18 | +3,783.50% | 2 | May 16, 2023 | |
| TPST Tempest Therapeutics | Maintains: Buy | $8 → $14 | $3.44 | +306.98% | 2 | Apr 28, 2023 | |
| PCSA Processa Pharmaceuticals | Maintains: Speculative Buy | $180 → $80 | $2.10 | +3,709.52% | 1 | Apr 4, 2023 | |
| ADVM Adverum Biotechnologies | Initiates: Buy | $20 | $9.53 | +109.86% | 1 | Mar 7, 2023 | |
| NRBO NeuroBo Pharmaceuticals | Initiates: Buy | $48 | $3.23 | +1,386.07% | 1 | Dec 7, 2022 | |
| CALA Calithera Biosciences | Downgrades: Neutral | n/a | $0.02 | - | 2 | Nov 15, 2022 | |
| NXTC NextCure | Downgrades: Neutral | n/a | $1.17 | - | 4 | Nov 4, 2022 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $15 | $5.33 | +181.43% | 1 | Oct 26, 2022 | |
| ALLR Allarity Therapeutics | Downgrades: Neutral | n/a | $1.38 | - | 2 | Aug 23, 2022 | |
| ANEB Anebulo Pharmaceuticals | Initiates: Buy | $6 | $2.75 | +118.18% | 1 | Jul 27, 2022 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $21 | $6.38 | +229.15% | 1 | Jul 13, 2022 | |
| QNRX Quoin Pharmaceuticals | Initiates: Buy | $300 | $0.69 | +43,689.23% | 1 | May 6, 2022 | |
| ANVS Annovis Bio | Initiates: Buy | $37 | $7.28 | +408.24% | 1 | May 2, 2022 | |
| CMPX Compass Therapeutics | Initiates: Buy | $7 | $1.46 | +379.45% | 1 | Mar 15, 2022 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | n/a | $1.46 | - | 3 | Nov 8, 2021 | |
| REGN Regeneron Pharmaceuticals | Downgrades: Hold | n/a | $892.48 | - | 6 | Nov 5, 2021 | |
| INCY Incyte | Upgrades: Buy | n/a | $52.56 | - | 2 | Jul 20, 2021 | |
| SCPS Scopus BioPharma | Initiates: Speculative Buy | n/a | $0.00 | - | 1 | Feb 16, 2021 | |
| NBIX Neurocrine Biosciences | Initiates: Hold | n/a | $138.89 | - | 1 | Sep 30, 2020 | |
| SLRX Salarius Pharmaceuticals | Initiates: Speculative Buy | n/a | $0.48 | - | 1 | Jun 16, 2020 | |
| INO Inovio Pharmaceuticals | Initiates: Buy | $336 | $11.50 | +2,821.74% | 1 | May 21, 2020 | |
| VYGR Voyager Therapeutics | Initiates: Buy | n/a | $7.77 | - | 1 | Mar 19, 2020 |
Aileron Therapeutics
Apr 18, 2024
Maintains: Buy
Price Target: $9 → $19
Current: $4.92
Upside: +286.18%
Acrivon Therapeutics
Apr 5, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $10.00
Upside: +40.00%
Spruce Biosciences
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.71
Upside: -
Biodexa Pharmaceuticals
Feb 8, 2024
Initiates: Buy
Price Target: $8
Current: $1.31
Upside: +510.69%
PMV Pharmaceuticals
Dec 27, 2023
Initiates: Buy
Price Target: $7
Current: $1.77
Upside: +295.48%
Zura Bio
Oct 10, 2023
Initiates: Buy
Price Target: $10
Current: $4.64
Upside: +115.52%
Coeptis Therapeutics
Sep 22, 2023
Initiates: Buy
Price Target: $3
Current: $0.33
Upside: +795.79%
Cognition Therapeutics
Aug 14, 2023
Maintains: Buy
Price Target: $10 → $6
Current: $1.93
Upside: +210.88%
Alterity Therapeutics
Jun 5, 2023
Maintains: Buy
Price Target: $20 → $10
Current: $2.20
Upside: +355.58%
Corvus Pharmaceuticals
May 30, 2023
Maintains: Buy
Price Target: $4 → $10
Current: $1.58
Upside: +532.91%
Palisade Bio
May 16, 2023
Maintains: Buy
Price Target: $375 → $240
Current: $6.18
Upside: +3,783.50%
Tempest Therapeutics
Apr 28, 2023
Maintains: Buy
Price Target: $8 → $14
Current: $3.44
Upside: +306.98%
Processa Pharmaceuticals
Apr 4, 2023
Maintains: Speculative Buy
Price Target: $180 → $80
Current: $2.10
Upside: +3,709.52%
Adverum Biotechnologies
Mar 7, 2023
Initiates: Buy
Price Target: $20
Current: $9.53
Upside: +109.86%
NeuroBo Pharmaceuticals
Dec 7, 2022
Initiates: Buy
Price Target: $48
Current: $3.23
Upside: +1,386.07%
Calithera Biosciences
Nov 15, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.02
Upside: -
NextCure
Nov 4, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.17
Upside: -
Capricor Therapeutics
Oct 26, 2022
Initiates: Buy
Price Target: $15
Current: $5.33
Upside: +181.43%
Allarity Therapeutics
Aug 23, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.38
Upside: -
Anebulo Pharmaceuticals
Jul 27, 2022
Initiates: Buy
Price Target: $6
Current: $2.75
Upside: +118.18%
Nuvectis Pharma
Jul 13, 2022
Initiates: Buy
Price Target: $21
Current: $6.38
Upside: +229.15%
Quoin Pharmaceuticals
May 6, 2022
Initiates: Buy
Price Target: $300
Current: $0.69
Upside: +43,689.23%
Annovis Bio
May 2, 2022
Initiates: Buy
Price Target: $37
Current: $7.28
Upside: +408.24%
Compass Therapeutics
Mar 15, 2022
Initiates: Buy
Price Target: $7
Current: $1.46
Upside: +379.45%
Nektar Therapeutics
Nov 8, 2021
Upgrades: Buy
Price Target: n/a
Current: $1.46
Upside: -
Regeneron Pharmaceuticals
Nov 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $892.48
Upside: -
Incyte
Jul 20, 2021
Upgrades: Buy
Price Target: n/a
Current: $52.56
Upside: -
Scopus BioPharma
Feb 16, 2021
Initiates: Speculative Buy
Price Target: n/a
Current: $0.00
Upside: -
Neurocrine Biosciences
Sep 30, 2020
Initiates: Hold
Price Target: n/a
Current: $138.89
Upside: -
Salarius Pharmaceuticals
Jun 16, 2020
Initiates: Speculative Buy
Price Target: n/a
Current: $0.48
Upside: -
Inovio Pharmaceuticals
May 21, 2020
Initiates: Buy
Price Target: $336
Current: $11.50
Upside: +2,821.74%
Voyager Therapeutics
Mar 19, 2020
Initiates: Buy
Price Target: n/a
Current: $7.77
Upside: -